Hims & Hers peptide treatments.
Courtesy: Hims & Hers
Hims & Hers Health on Wednesday said it will offer five formulations of peptides and longevity treatments compounded in the U.S. as part of the initial rollout of its Peptides+ platform, all of which are not approved by regulators.
Even as it announced the new products, Hims & Hers acknowledged it has more to learn about how best to use the peptides and how effective they are — underscoring the uncertainty surrounding the growing space.
The new offerings come after the federal government eased restrictions on compounding certain unapproved peptides, which are short chains of amino ​acids. Those products have exploded in popularity among fitness and longevity enthusiasts who attest that they help with muscle growth, rapid injury recovery and anti-aging, even though most lack evidence from robust human trials.
Hims in late October launched an early access list for the upcoming…